Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-α 2a

Neurology

Volumn 50, Issue 1, 1998, Pages 84-87

  Gorson, K C ^a,b   Ropper, A H ^a   Clark, B D ^a   Dew III, R B ^a   Simovic, D ^a   Allam, G ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DEMYELINATING DISEASE; DRUG EFFECT; DYNAMOMETRY; ELECTRODIAGNOSIS; GRIP STRENGTH; HUMAN; IMMUNOMODULATION; PLASMAPHERESIS; POLYNEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0031883822     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.1.84     Document Type: Article

References (10)

1. Dyck PJ, Prineas J, Pollard J. Chronic inflammatory demyelinating polyneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Podulos JF, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1993:1498-1517.
2. Hahn AF, Bolton CF, Zochodne D, Feasby TE. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled cross-over study. Brain 1996;119:1067-1077.
3. Hahn AF, Bolton CF, Pillay N, et al. Plasma exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind sham-controlled, cross-over study. Brain 1996; 119:1055-1066.
4. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without monoclonal gammopathy. Neurology 1997;48:321-328.
5. Sabatelli M, Mignona T, Lippi G, Milone M, Lazzaro VD, Tonali P. Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1995;58:638-639.
6. Gorson KC, Allam G, Simovic D, Ropper AH. Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy. Neurology 1997;48:777-780.
7. Rentzos H, Nikolaou C, Rombos A, Voumvourakis K, Segditsa I, Papageorgiou C. Tumor necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies. J Neurol 243;2:165-170.
8. Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 1991;30:48-53.
9. Leger JM, Mariette X, Chastang C, et al. A randomized trial comparing alpha-interferon and intravenous gammaglobulin in polyneuropathy associated with IgM monoclonal gammopathy (abstract). Neurology 1996;46:A380.
10. Khella SL, Frost S, Hermann GA, et al. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alpha: case report and literature review. Neurology 1995;45:407-411.